Elobixibat
Elobixibat is an IBAT inhibitor, undergoing development in clinical trials for the treatment of chronic constipation and irritable bowel syndrome with constipation (IBS-C).
primaryTopic
Elobixibat
Elobixibat is an IBAT inhibitor, undergoing development in clinical trials for the treatment of chronic constipation and irritable bowel syndrome with constipation (IBS-C).
has abstract
Elobixibat is an IBAT inhibito ...... ome with constipation (IBS-C).
@en
ATC prefix
CAS number
439087-18-0
FDA UNII code
865UEK4EJC
IUPAC name
N-{(2R)-2-[({[3,3-Dibutyl-7-(m ...... )amino]-2-phenylacetyl}glycine
@en
PubChem
thumbnail
Wikipage page ID
36.881.440
Wikipage revision ID
719.109.868
ChEMBL
ChemSpiderID
legal status
Investigational
molecular weight
routes of administration
smiles
O=CCNC[C@@H]NCCOc4cc3ccc4SC
StdInChI
InChI=1S/C36H45N3O7S2/c1-4-6-1 ...... 8-19,22-25H2,1-3H3,/t34-/m1/s1
StdInChIKey
XFLQIRAKKLNXRQ-UUWRZZSWSA-N
subject
hypernym
comment
Elobixibat is an IBAT inhibito ...... ome with constipation (IBS-C).
@en
label
Elobixibat
@en